Last reviewed · How we verify

NCT02158195: IAHAI

Immunopathology of Autoimmune Hemolytic Anemia

Completed Last updated 9 February 2026
What this trial tests

trial testing blood samples in Autoimmune Hemolytic Anemia in 27 participants. Completed in 27 December 2018.

Timeline
3 July 2013
Primary endpoint
27 December 2018
27 December 2018

Quick facts

Lead sponsorCentre Hospitalier Universitaire Dijon
StatusCompleted
Study typeOBSERVATIONAL
Enrollment27
Start date3 July 2013
Primary completion27 December 2018
Estimated completion27 December 2018
Sites5 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire Dijon

Who can join

16 and older, any sex, with Autoimmune Hemolytic Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Autoimmune hemolytic anemia (AIHA) is an auto-immune disease mediated by specific antibodies targeting red blood cells. Its pathogenesis is not completely understood, and the role of T cells have been rarely studied. The aim of this study is to compare the frequency of circulating T cells, T cell polarization and functions, notably regulatory T cells, during warm AIHA by comparison to healthy controls. The role of treatments, such as steroids, will also be determined in patients with warm AIHA.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Venous thromboembolic events during warm autoimmune hemolytic anemia.
    Audia S, Bach B, Samson M, Lakomy D, et al · · 2018 · cited 56× · PMID 30408135 · DOI 10.1371/journal.pone.0207218
  2. Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor α in autoimmune hemolytic anemia and participate in Th17 polarization.
    Ciudad M, Ouandji S, Lamarthée B, Cladière C, et al · · 2024 · cited 11× · PMID 37534543 · DOI 10.3324/haematol.2023.282859

Verify or expand the search:

Other trials of blood samples

Trials testing the same drug.

Other recruiting trials for Autoimmune Hemolytic Anemia

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire Dijon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02158195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing